Normal 0 false false false MicrosoftInternetExplorer4 Clovis Oncology (NASDAQ: CLVS) shares fell 38.3% to $11.27. Clovis Oncology reported negative outcome of CO-101 in pivotal LEAP pancreatic cancer study. Share volume was 966,000, dwarfing a daily average of less than 71,000. /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman"; mso-ansi-language:#0400; mso-fareast-language:#0400; mso-bidi-language:#0400;}